AnaptysBio Inc (ANAB)
22.59
+1.21
(+5.66%)
USD |
NASDAQ |
Mar 28, 16:00
22.56
-0.03
(-0.13%)
After-Hours: 20:00
AnaptysBio Profit Margin (Quarterly): -468.8% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -468.8% |
September 30, 2023 | -1.12K% |
June 30, 2023 | -1.15K% |
March 31, 2023 | -3.22K% |
December 31, 2022 | -388.0% |
September 30, 2022 | -2.59K% |
June 30, 2022 | -2.68K% |
March 31, 2022 | -3.74K% |
December 31, 2021 | -3.22K% |
September 30, 2021 | -31.91% |
June 30, 2021 | -1.43% |
March 31, 2021 | -161.5% |
December 31, 2020 | 56.08% |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | -55.08% |
December 31, 2019 | -675.4% |
September 30, 2019 | |
June 30, 2019 | -479.2% |
Date | Value |
---|---|
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | -319.2% |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | -228.7% |
September 30, 2017 | |
June 30, 2017 | -38.34% |
March 31, 2017 | |
December 31, 2016 | -166.2% |
September 30, 2016 | -34.69% |
June 30, 2016 | 39.69% |
March 31, 2016 | -18.25% |
December 31, 2015 | -86.63% |
September 30, 2015 | -32.22% |
June 30, 2015 | -1.13% |
March 31, 2015 | -9.18% |
December 31, 2014 | 13.55% |
September 30, 2014 | 56.19% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.74K%
Minimum
Mar 2022
56.08%
Maximum
Dec 2020
-1.25K%
Average
-577.3%
Median
Profit Margin (Quarterly) Benchmarks
Puma Biotechnology Inc | 17.00% |
Corcept Therapeutics Inc | 23.16% |
Sarepta Therapeutics Inc | 11.51% |
Collegium Pharmaceutical Inc | 21.33% |
Nuvalent Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -101.0% |
Return on Assets | -31.24% |
Return on Invested Capital | -101.0% |
Operating Margin (Quarterly) | -386.4% |
Return on Net Operating Assets | -731.1% |